BIOMAT Database Logo BIOMAT Database Logo

[Cryptorchism. Treatment with human chorionic gonadotropin or gonadotropin-releasing hormone?]. 1993

P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Børneafdelingen, Hvidovre Hospital, København.

In a modified double-blind study on the effect of human chorionic gonadotrophin (hCG), gonadotrophin releasing hormone (GnRH) and placebo, 163 prepubertal boys (aged 1.8-13.0) with bilateral and 94 (aged 1.5-13.1 years) with unilateral cryptorchidism fulfilled the inclusion criteria and completed the treatment protocol. hCG was administered as intramuscular injections twice weekly for three weeks. GnRH and placebo were given intranasally. hCG was superior to GnRH and placebo in the treatment of both bilateral (p < 0.0016) and unilateral (p < 0.013) cryptorchidism with success rates of respectively 23% and 19%. Linear and logistic regression analysis on the results obtained by treatment of bilateral disease showed that all treatments were more successful the younger the age of the boys. The data indicated that bilateral and unilateral cryptorchidism respond differently to hormonal treatment. We conclude that the success rates obtained in this study justify the use of hCG in prepubertal boys with cryptorchidism.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003456 Cryptorchidism A developmental defect in which a TESTIS or both TESTES failed to descend from high in the ABDOMEN to the bottom of the SCROTUM. Testicular descent is essential to normal SPERMATOGENESIS which requires temperature lower than the BODY TEMPERATURE. Cryptorchidism can be subclassified by the location of the maldescended testis. Testis, Undescended,Abdominal Cryptorchidism,Bilateral Cryptorchidism,Cryptorchidism, Unilateral Or Bilateral,Cryptorchism,Inguinal Cryptorchidism,Testes, Undescended,Undescended Testis,Unilateral Cryptorchidism,Cryptorchidism, Abdominal,Cryptorchidism, Bilateral,Cryptorchidism, Inguinal,Cryptorchidism, Unilateral,Undescended Testes
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic

Related Publications

P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Maintenance of pregnancy in dairy cattle after treatment with human chorionic gonadotropin or gonadotropin-releasing hormone.
August 2008, Journal of dairy science,
P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
[Treatment of cryptorchism with human chorionic gonadotropin. Problem of dosage].
October 1971, Wiener medizinische Wochenschrift (1946),
P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment.
May 2015, Veterinary world,
P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Gonadotropin-releasing hormone effects on placental hormones during gestation: I. Alpha-human chorionic gonadotropin, human chorionic gonadotropin and human chorionic somatomammotropin.
March 1986, Biology of reproduction,
P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Lack of release of human chorionic gonadotropin by gonadotropin-releasing hormone.
December 1976, Endocrinologia japonica,
P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Gonadotropin-releasing hormone increases serum human chorionic gonadotropin in pregnant women.
October 1993, Endocrine journal,
P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Endometrial biopsies during treatment with subcutaneous pulsatile gonadotropin-releasing hormone and luteal-phase human chorionic gonadotropin.
January 1988, International journal of fertility,
P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
June 2018, Journal of the Turkish German Gynecological Association,
P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Ovarian response to human chorionic gonadotropin or gonadotropin releasing hormone in cats in natural or induced estrus.
May 1987, Theriogenology,
P Christiansen, and J R Müller, and S B Buhl, and O R Hansen, and N Hobolth, and B B Jacobsen, and P I Jørgensen, and K W Kastrup, and K Nielsen, and L B Nielsen
Primary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: a clinical trial.
January 1997, Urology,
Copied contents to your clipboard!